Dose-effect Relationship of Bolus 5-Fluorouracil in the Treatment of Advanced Colorectal Cancer

Author： Jakobsen Anders   Berglund Åke   Glimelius Bengt   Frödin Jan-Erik   Hansen Flemming   Kjaer Mogens   Lindegaard Madsen Ebbe   Sandberg Erik   Poulsen Jan Peter   Carlsson Göran   Gustavsson Bengt  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.41, Iss.6, 2002-10, pp. : 525-531

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of Advanced Colorectal Cancer with High-dose Intensity Folinic Acid and 5-Fluorouracil Plus Supportive Care

By Petrioli R.   Lorenzi M.   Aquino A.   Marsili S.   Frediani B.   Palazzuoli V.   Marzocca G.   Botta G.   Tani F.   De Martino A.   Testi W.   Setacci C.   Salvestrini F.   De Sando D.   Bovenga S.   Mariani L.   Mancini S.   Tanzini G.   Armenio S.   Marinello E.   Francini G.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2105-2108

Elsevier

Access to resources Recommend Favorite

Treatment of advanced colorectal cancer with 5-fluorouracil and interferon- : An overview of clinical trials

By Raderer M.   Scheithauer W.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 1002-1008

Elsevier

Access to resources Recommend Favorite

Nordic 5-Fluorouracil/Leucovorin Bolus Schedule Combined with Oxaliplatin (Nordic FLOX) as First-line Treatment of Metastatic Colorectal Cancer

By Sørbye Halfdan   Dahl Olav  

Acta Oncologica, Vol. 42, Iss. 8, 2003-12 ,pp. : 827-831

Informa Healthcare

Access to resources Recommend Favorite

High Dose 5-Fluorouracil (5-FU) and Folinic Acid in Advanced Colorectal Cancer Resistant to Standard Dose 5-FU Treatment: Results of a Phase II Study

By Jager E.   Klein O.   Wachter B.   Muller B.   Braun U.   Knuth A.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1717-1717

Elsevier

Access to resources Recommend Favorite

CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer

By Andre T.   Louvet C.   Maindrault-Goebel F.   Couteau C.   Mabro M.   Lotz J.P.   Gilles-Amar V.   Krulik M.   Carola E.   Izrael V.   de Gramont A.  

European Journal of Cancer, Vol. 35, Iss. 9, 1999-09 ,pp. : 1343-1347

Elsevier

Access to resources Recommend Favorite